My colleagues and I are seeking to define gene mutations that cause pediatric heart disease so that we can better treat or prevent these conditions.

About

Biography

As a general pediatric cardiologist, I see outpatients for congenital heart disease, cardiomyopathy, genetic disorders and other issues. In my practice, I talk to patients directly and take time to answer all questions from patients and their families.

I was inspired to pursue my career by David Goldring, MD, who was the director of pediatric cardiology at St. Louis Children’s Hospital for many years.

In addition to helping patients and their families, I’m involved in research. My colleagues and I are seeking to define gene mutations that cause pediatric heart disease so that we can better treat or prevent these conditions.

I was honored to receive the 2006 American Heart Association’s Basic Science Research Award for work that led to finding genetic defects that can cause heart failure and sudden death in infants and children. I also received the 1991 E. Mead Johnson Award for Excellence in Pediatric Research and was elected to the National Academy of Medicine.

In my spare time, I love watching baseball and going to the beach.

Additional Languages

French

Location

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

The Genomics Research and Innovation Network: creating an interoperable, federated, genomics learning system. Mandl, KD; Glauser, T; Krantz, ID; Avillach, P; Bartels, A; Beggs, AH; Biswas, S; Bourgeois, FT; Corsmo, J; Dauber, A; et al. Genetics in Medicine. 2020; 22:371-380.

Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases. Khuchua, Z; Glukhov, AI; Strauss, AW; Javadov, S. International Journal of Molecular Sciences. 2018; 19.

The Effects of PPAR Stimulation on Cardiac Metabolic Pathways in Barth Syndrome Mice. Schafer, C; Moore, V; Dasgupta, N; Javadov, S; James, JF; Glukhov, AI; Strauss, AW; Khuchua, Z. Frontiers in Pharmacology. 2018; 9.

The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndrome. Huang, Y; Powers, C; Moore, V; Schafer, C; Ren, M; Phoon, CK L; James, JF; Glukhov, AV; Javadov, S; Vaz, FM; et al. Orphanet Journal of Rare Diseases. 2017; 12.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey